Bolsonaro seeks Israeli anti-COVID nasal spray for Brazil | ABS-CBN

Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!
Bolsonaro seeks Israeli anti-COVID nasal spray for Brazil
Bolsonaro seeks Israeli anti-COVID nasal spray for Brazil
Agence France-Presse
Published Feb 18, 2021 01:37 PM PHT

BRASILIA — Brazilian President Jair Bolsonaro said Monday his government would seek emergency use authorization for an Israeli-developed nasal spray against COVID-19 that Prime Minister Benjamin Netanyahu described as a "miracle" treatment.
BRASILIA — Brazilian President Jair Bolsonaro said Monday his government would seek emergency use authorization for an Israeli-developed nasal spray against COVID-19 that Prime Minister Benjamin Netanyahu described as a "miracle" treatment.
"EXO-CD24 is a nasal spray developed by the Ichilov Medical Center in Israel, with nearly 100-percent effectiveness -- 29 out of 30 -- against COVID in serious cases," Bolsonaro tweeted, two days after speaking on the phone with Netanyahu, who calls the Brazilian far-right leader a "good friend."
"EXO-CD24 is a nasal spray developed by the Ichilov Medical Center in Israel, with nearly 100-percent effectiveness -- 29 out of 30 -- against COVID in serious cases," Bolsonaro tweeted, two days after speaking on the phone with Netanyahu, who calls the Brazilian far-right leader a "good friend."
"A request to analyze this medication for emergency use will be sent shortly to (federal health regulator) Anvisa," Bolsonaro wrote.
"A request to analyze this medication for emergency use will be sent shortly to (federal health regulator) Anvisa," Bolsonaro wrote.
- EXO-CD24 é um spray nasal desenvolvido pelo Centro Médico Ichilov de Israel, com eficácia próxima de 100% (29/30), em casos graves, contra a Covid.
- Brevemente será enviado à ANVISA o pedido de análise para uso emergencial do medicamento. pic.twitter.com/BldSkzYZo0
— Jair M. Bolsonaro (@jairbolsonaro) February 15, 2021
- EXO-CD24 é um spray nasal desenvolvido pelo Centro Médico Ichilov de Israel, com eficácia próxima de 100% (29/30), em casos graves, contra a Covid.
— Jair M. Bolsonaro (@jairbolsonaro) February 15, 2021
- Brevemente será enviado à ANVISA o pedido de análise para uso emergencial do medicamento. pic.twitter.com/BldSkzYZo0
The Ichilov Medical Center announced two weeks ago that one of its researchers had carried out Phase One testing -- typically the first of three phases of clinical trials -- on a nasal spray he developed against respiratory symptoms linked to COVID-19.
The Ichilov Medical Center announced two weeks ago that one of its researchers had carried out Phase One testing -- typically the first of three phases of clinical trials -- on a nasal spray he developed against respiratory symptoms linked to COVID-19.
ADVERTISEMENT
RELATED STORIES:
The researcher, Nadir Arber, reported he had administered the spray to 30 patients with moderate to severe cases of COVID-19, and that 29 of them had been released from hospital in three to five days.
The researcher, Nadir Arber, reported he had administered the spray to 30 patients with moderate to severe cases of COVID-19, and that 29 of them had been released from hospital in three to five days.
But the medical center did not say whether a placebo had been given to a control group, and has yet to publish its findings in a peer-reviewed scientific journal.
But the medical center did not say whether a placebo had been given to a control group, and has yet to publish its findings in a peer-reviewed scientific journal.
In order to be accepted as effective by scientists, new treatments must generally undergo randomized, controlled, blind clinical trials that are then shared in a research publication.
In order to be accepted as effective by scientists, new treatments must generally undergo randomized, controlled, blind clinical trials that are then shared in a research publication.
RELATED VIDEO: How does a pandemic end? | NXT
However, that did not stop Netanyahu from hailing EXO-CD24 as a "miracle" drug last week.
However, that did not stop Netanyahu from hailing EXO-CD24 as a "miracle" drug last week.
Bolsonaro, too, has been eager to embrace experimental treatments against COVID-19, even when health experts question them.
Bolsonaro, too, has been eager to embrace experimental treatments against COVID-19, even when health experts question them.
ADVERTISEMENT
A fierce critic of lockdown measures, which he says unnecessarily harm the economy, he has instead fervently pushed the anti-malaria drugs chloroquine and hydroxychloroquine to fight Covid-19.
A fierce critic of lockdown measures, which he says unnecessarily harm the economy, he has instead fervently pushed the anti-malaria drugs chloroquine and hydroxychloroquine to fight Covid-19.
He took the latter himself when he tested positive last July, despite scientists' findings that the two drugs are ineffective against the new coronavirus.
He took the latter himself when he tested positive last July, despite scientists' findings that the two drugs are ineffective against the new coronavirus.
Bolsonaro has sought to cultivate close ties with Netanyahu.
Bolsonaro has sought to cultivate close ties with Netanyahu.
In one of his first moves after winning election in 2018, he vowed to follow the lead of his political role model, then US president Donald Trump, and move Brazil's embassy in Israel from Tel Aviv to Jerusalem -- despite Palestinian claims to parts of the city.
In one of his first moves after winning election in 2018, he vowed to follow the lead of his political role model, then US president Donald Trump, and move Brazil's embassy in Israel from Tel Aviv to Jerusalem -- despite Palestinian claims to parts of the city.
bur-jhb/jm
© Agence France-Presse
Read More:
Brazil
COVID-19
COVID-19 vaccine
Brazil COVID-19
EXO-CD24
Nadir Arber
President Jair Bolsonaro
Brazil vaccination
Ichilov Medical Center
Israeli COVID-19 nasal spray
ADVERTISEMENT
ADVERTISEMENT